Does Kaiser Permanente Cover Enbrel?
The verdict
Covered on most plans
Kaiser Permanente covers Enbrel on its closed formulary with prior authorization and step therapy, with all prescribing and dispensing handled inside the Kaiser integrated system. Step therapy typically routes through a preferred TNF or adalimumab biosimilar first, since no etanercept biosimilar is marketed — Erelzi and Eticovo are FDA-approved but legally blocked until April 24, 2029. For Kaiser Medicare members, Enbrel's CMS-negotiated price is effective January 1, 2026.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Kaiser Permanente using your member ID.
Key facts
No etanercept biosimilar will be available in the US until April 24, 2029 — Erelzi and Eticovo are FDA-approved but blocked by patent litigation protecting Amgen's US Patent 8,163,522.
Center for Biosimilars; US District Court for the District of New Jersey, November 2021
Enbrel is one of the first 10 Medicare Part D drugs with a CMS-negotiated price; negotiated prices took effect January 1, 2026.
CMS Medicare Drug Price Negotiation Program, August 2023
Kaiser's closed integrated model means Enbrel is prescribed, authorized, and dispensed entirely within Kaiser — no outside specialist or specialty pharmacy is permitted.
Kaiser Permanente integrated care model / formulary
Medicare vs. commercial coverage
Whether Kaiser Permanente covers Enbrel depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare (Kaiser Senior Advantage Part D): Enbrel is covered on Kaiser's formulary with PA and step therapy, dispensed through Kaiser's internal specialty pharmacy. Enbrel is one of the first 10 Medicare Part D drugs with a CMS-negotiated price, effective January 1, 2026, which lowers the program's drug cost. The 2026 Part D out-of-pocket cap of $2,100 limits the Medicare member's annual exposure. Coinsurance is typically 25–33% after the deductible. Kaiser's manufacturer savings-card policies within the closed system may be more restrictive — verify with your Kaiser plan.
Commercial / Employer
Group & marketplace plans
Commercial/Employer (Kaiser HMO): Enbrel is covered on Kaiser's closed formulary with PA and internal step therapy, dispensed by Kaiser's own specialty pharmacy. Members must see a Kaiser rheumatologist, dermatologist, or specialist — no external prescribers or specialty pharmacies. Step therapy typically requires a trial of a preferred TNF inhibitor or adalimumab biosimilar first; no etanercept biosimilar is available (blocked to 2029), so the step agent is not an etanercept product. ACA/Individual (Kaiser marketplace): covered with PA where offered in Kaiser service areas. Medicaid (Kaiser Medi-Cal/managed): covered for approved indications per contract with PA; nominal cost-share.
The 5 boxes you must tick to get approved
Commercial plans that will consider Enbrel require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Enbrel actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
List price approximately $2,039.40 per 50 mg weekly syringe, approximately $8,150/month per Amgen (estimate). Treat as estimate — verify with pharmacy.
List price with no coverage — before any manufacturer savings card.
With coverage
Kaiser plan cost-share per member plan (copay or coinsurance per Kaiser plan design). Kaiser Medicare: typically 25–33% coinsurance after the deductible, capped at $2,100 for the year (2026 Part D OOP limit); CMS-negotiated price effective 1/1/2026 lowers program cost. Medicaid: nominal cost-share per Kaiser Medi-Cal contract.
Typical monthly copay once prior authorization is approved.
Bridge program
Manufacturer savings cards (Enbrel Support program) are generally not usable within Kaiser's closed system — verify with your Kaiser plan. Kaiser Medicare beneficiaries are not eligible for manufacturer assistance programs. Patients experiencing financial hardship should contact Kaiser member services or Amgen's patient-assistance program.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Cost-share varies by Kaiser plan. Confirm your specific out-of-pocket cost with your Kaiser plan before starting treatment.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Request a referral to a Kaiser rheumatologist or specialist
Coverage and PA for Enbrel within Kaiser starts with a referral to a Kaiser rheumatologist, dermatologist, or other specialist for your indication (RA, psoriatic arthritis, plaque psoriasis, etc.). Your Kaiser primary-care physician can initiate this referral.
- 2
Check Kaiser's drug formulary online
Log in to kp.org and use the drug lookup tool to confirm Enbrel's status on your specific Kaiser plan. You can view tier placement, PA requirements, and step-therapy prerequisites. Contact Kaiser member services at the number on your member ID card for plan-specific details.
- 3
Have your Kaiser specialist submit the internal prior authorization
Your Kaiser rheumatologist or specialist will submit the PA through Kaiser's internal process, including diagnosis documentation, step-therapy history (prior biologics tried), and clinical rationale. Because Kaiser is a closed system, the PA, dispensing, and follow-up all happen within the Kaiser network.
Options if Kaiser Permanente won't cover Enbrel
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Adalimumab biosimilars (Amjevita, Hyrimoz, others)
Adalimumab biosimilars are the likely step-therapy option Kaiser requires before Enbrel. They are available at lower cost than branded Humira and may be Kaiser's preferred TNF inhibitor on its closed formulary. Ask your Kaiser rheumatologist.
Methotrexate (MTX)
A first-line conventional DMARD for RA and psoriatic arthritis, typically covered at low cost on Kaiser's formulary. Documented MTX trial and failure is commonly required before any biologic DMARD is approved.
Amgen EnSpring patient support (non-Kaiser Medicare)
Amgen's Enbrel Support program offers copay assistance for eligible commercially insured patients outside Kaiser's closed system. Not applicable within Kaiser or for Medicare beneficiaries. Contact Amgen at 1-888-4ENBREL for details.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes. Kaiser covers Enbrel on its closed formulary with prior authorization and step therapy. The unique feature is Kaiser's integrated model: Enbrel must be prescribed by a Kaiser specialist and dispensed by Kaiser's own specialty pharmacy — no external providers. Step therapy typically requires a trial of a preferred TNF or adalimumab biosimilar first. Verify coverage details on your specific Kaiser plan at kp.org.
No. Two etanercept biosimilars — Erelzi and Eticovo — are FDA-approved but cannot be marketed in the US due to patent litigation protecting Amgen's US Patent 8,163,522. Per court rulings and the Center for Biosimilars, neither can launch until April 24, 2029. So when Kaiser asks you to try a lower-cost agent first, it will be a different biologic (such as an adalimumab biosimilar), not an etanercept biosimilar.
Enbrel is one of the first 10 Medicare Part D drugs with a CMS-negotiated price, effective January 1, 2026. The negotiation lowers the program's cost for Medicare Part D, but its direct effect on your copay depends on your plan's cost-sharing structure. The 2026 Part D out-of-pocket cap of $2,100 provides the primary protection for your annual out-of-pocket spending. Confirm your plan-specific cost with Kaiser.
No. Kaiser is a closed integrated system — Enbrel must be prescribed by a Kaiser rheumatologist or specialist and dispensed through Kaiser's own specialty pharmacy. External prescriptions are not accepted within the Kaiser dispensing network. If your condition requires a subspecialist not available within Kaiser, your Kaiser physician can discuss referral options, but the prescription and dispensing must remain within the Kaiser system for coverage to apply.
For Kaiser Medicare Senior Advantage members with Part D coverage, the 2026 Part D out-of-pocket cap of $2,100 limits your total annual spending on all covered Part D drugs. Since Enbrel costs approximately $8,150/month, most Medicare members will reach the cap within one to two months and pay nothing further for the rest of the year. Coinsurance before reaching the cap is typically 25–33% after the deductible. Confirm with your Kaiser plan.
Related Articles
Does Kaiser Permanente Cover Vyvanse? | Curex
Kaiser Permanente covers Vyvanse on its closed formulary via Kaiser pharmacies — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL.
Read moreDoes Kaiser Permanente Cover Qsymia? 2026 | Curex
Kaiser's closed HMO limits Qsymia access; Medi-Cal excluded weight-loss drugs in 2026. Engage cash program ~$89/mo; generic launched 2025.
Read moreDoes Kaiser Permanente Cover Cialis? 2026 | Curex
Kaiser Permanente does not cover Cialis for ED — Medicare Part D bars it by law and commercial plans exclude it. Generic tadalafil IS covered for BPH.
Read moreDoes Kaiser Permanente Cover Jardiance? 2026
Kaiser Permanente covers Jardiance on its closed-network formulary for T2D. Metformin-first step may apply. 2026 MFP $197; $2,100 cap for Medicare.
Read moreDoes Kaiser Permanente Cover Ozempic? 2026 Guide | Curex
Kaiser NW covers Ozempic for T2D — requires metformin plus SGLT-2 step therapy, strictest in the cluster. Tier 3, closed network, weight-loss excluded.
Read moreDoes Kaiser Permanente Cover Viagra? 2026 Guide
Kaiser Permanente does not cover Viagra for ED. The Medicare Part D statutory exclusion applies. Only covered path: sildenafil (Revatio) for PAH.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Kaiser Permanente before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.